SMMT
Summit Therapeutics·NASDAQ
--
--(--)
--
--(--)
SMMT fundamentals
Summit Therapeutics (SMMT) released its earnings on Feb 23, 2026: revenue was 0 (YoY --), met estimates; EPS was -0.14 (YoY -75.00%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.14
-75.00%
Report date
Feb 23, 2026
SMMT Earnings Call Summary for Q4,2025
- Revenue Growth: 15% YoY driven by North American recovery.
- AI Strategy: Continued investment with H2 gross margin improvement.
- Clinical Momentum: 60+ Phase III trials, including GSK/B7-H3 combo.
- Financial Strength: $713M cash, 5% opex decline, $1.08 EPS beat.
- Regulatory Focus: FDA BLA review with Q2 HARMONi-3 PFS readout.
- Commercial Prep: Hiring for EGFR launch; broader NSCLC expansion planned.
Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Summit Therapeutics (SMMT) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Summit Therapeutics (SMMT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Summit Therapeutics (SMMT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Summit Therapeutics (SMMT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Summit Therapeutics (SMMT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Summit Therapeutics (SMMT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Summit Therapeutics year over year?What guidance did Summit Therapeutics's management provide for the next earnings period?Did Summit Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Summit Therapeutics’s earnings call?What is Summit Therapeutics's gross profit margin?What factors drove the changes in Summit Therapeutics's revenue and profit?What is Summit Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Summit Therapeutics's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
